The view
Everpure closed at $107.99 in the reading of 13 November 2026, with the share price changing +21.9% over the past year. The platform's Intrinsic Value model puts intrinsic value at $12.06 per share, a gap of −88.8% against the price, so the price sits far above what the blended valuation supports. The published 21-session view expects +0.49%, a nearly flat lean up. The published 63-session view expects +4.56%, a firmer lean up over the same direction.
Next month: why the model view is positive
The published 21-session view leans up only slightly, at +0.49%, with a probability of a rise of 56% and a band from −35.8% to +36.8%. The facts on the up side are trend: the close sits +23.8% from its 200-day average and 90.2% above its 52-week low. Against that, short-term acceleration is the lowest in five years and the average true range is the highest in five years, while the market regime is strong risk-off. The 200 past situations like today's, which are history and not a forecast, returned a median +1.4% over the next 21 sessions and rose in 55% of cases. That history agrees with a mild upward lean.
Next 3 months: model view positive
The published 63-session view leans up at +4.56%, inside a very wide band from −50.4% to +59.5%. Both published views point the same way here, with the longer horizon carrying a larger expected move, which can happen when trend and growth weigh more over three months than near-term noise. The facts carrying it are strong revenue momentum and a price well above its long average, while the strong risk-off regime and short-sale volume at percentile 75 within the sector argue for caution. Past situations like today's, as history only, returned a median +3.9% over the next 63 sessions and rose in 55% of cases, which broadly agrees with the lean.
The long term
The long-term case is where the evidence conflicts most. Intrinsic value of $12.06 sits −88.8% from the price, and the price-to-earnings multiple of 107.54 ranks at percentile 88 within the sector, with price-to-book at 16.69; the value family is among the lowest across the broad market. On the other side, return on equity is 17.7%, the Piotroski score is 6, revenue grew +37.7%, operating cash flow reached $427.81M, and profitability and balance-sheet health readings are the highest in five years. Past situations like today's, as history, returned a median +2.1% over the following year and rose in 51% of cases, close to a coin toss. Near-term views rest on trend and growth; the long-term caution rests on valuation.
How sure we are
Each horizon deserves limited weight. On this name, 50% of 282 matured 21-session forecasts matched the direction, close to the base rate of about half, so the record adds little conviction. The history rests on 200 past situations matched on seven measures, not on the 589 features in today's fingerprint. The bands are very wide, from −35.8% to +36.8% over 21 sessions and from −50.4% to +59.5% over 63 sessions, reflecting volatility that ranks near the top of the broad market and tail risk at the highest in five years.